Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia

European Journal of Haematology

Volumn 84, Issue 2, 2010, Pages 154-159

  Chang, Myung H ^a,b   Kim, Kyoung H ^a   Kim, Hyo S ^a   Jun, Hyun J ^a   Kim, Dong H ^a   Jang, Jun H ^a   Kim, Kihyun ^a   Jung, Chul W ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Immunosuppressive therapy; Predictive factor; Severe aplastic anemia

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BACTERIAL INFECTION; DRUG BLOOD LEVEL; DRUG RESPONSE; FEMALE; FOLLOW UP; HORSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEUTROPHIL COUNT; OVERALL SURVIVAL; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTOSIS; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RABBIT; RETICULOCYTE COUNT; SURVIVAL; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ANIMALS; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; DISEASE-FREE SURVIVAL; FEMALE; HORSES; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; RABBITS; RETICULOCYTE COUNT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 74049143812     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01378.x     Document Type: Article

References (13)

1. Marsh J. Making therapeutic decisions in adults with aplastic anemia. Hematology Am Soc Hematol Educ Program 2006 78 85. [review].
2. Bacigalupo A. Aplastic anemia: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program 2007 2007 : 23 8.
3. Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A, Schrezenmeier H, Passweg J, Fuhrer M. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2007 92 : 11 8.
4. Rosenfeld S, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 2003 289 : 1130 1135.
5. Di Bona E, Rodeghiero F, Bruno B, et al. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Br J Haematol 1999 107 : 330 334.
6. Scheinberg P, Wu CO, Nunez O, Young NS. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol 2009 144 : 206 216.
7. Fuhrer M, Rampf U, Baumann I, Faldum A, Niemeyer C, Janka-Schaub G, Friedrich W, Ebell W, Borkhardt A, Bender-Goetze C. Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood 2005 106 : 2102 2104.
8. Rozman C, Marin P, Granena A, Nomdedeu B, Montserrat E, Feliu E, Vives-Corrons JL. Prognosis in acquired aplastic anaemia. A multivariate statistical analysis of 80 cases. Scand J Haematol 1981 26 : 321 329.
9. Marsh JC, Hows JM, Bryett KA, Al-Hashimi S, Fairhead SM, Gordon-Smith EC. Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity. Blood 1987 70 : 1046 1052.
10. Bacigalupo A, Hows J, Gluckman E, et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol 1988 70 : 177 182. (Pubitemid 18238126)
11. Takami A, Nakao S, Tatsumi Y, Wang H, Weihua Z, Yamazaki H, Yasue S, Shiobara S, Matsuda T, Mizoguchi H. High inducibility of heat shock protein 72 (hsp72) in peripheral blood mononuclear cells of aplastic anaemia patients: a reliable marker of immune-mediated aplastic anaemia responsive to cyclosporine therapy. Br J Haematol 1999 106 : 377 384.
12. Song MK, Chung JS, Joo YD, Kim YS, Kim SH, Seol YM, Shin HJ, Choi YJ, Cho GJ. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia? Eur J Haematol 2009 83 : 72 8. [Epub ahead of print].
13. Sugimori C, Chuhjo T, Feng X, Yamazaki H, Takami A, Teramura M, Mizoguchi H, Omine M, Nakao S. Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood 2006 107 : 1308 1314.